Knoll Capital Management, LLC Diversified Active

Location: Miami, FL

CIK: 0001325083 · Show all filings

Period: Q1 2017 (← Previous) (Next →)

Filing Date: May 15, 2017

Total Value: $66.33M (100.0% shares, 0.0% debt)

Holdings (17)

— Corbus Pharmaceuticals HLDGS 46.5%

Value $30.85M Shares 3,738,925 Est. Cost $4.33 Unrealized —

— Abeona Therapeutics Inc 17.7%

Value $11.74M Shares 2,359,767 Est. Cost $4.97 Unrealized —

— Vascular Biogenics LTD 7.1%

Value $4.733M Shares 860,605 Est. Cost $4.61 Unrealized —

AVXL Anavex Life Sciences Corp 6.3%

Value $4.157M Shares 724,205 Est. Cost $3.56 Unrealized +45.0%

— Newlink Genetics Corp 3.4%

Value $2.254M Shares 93,533 Est. Cost $27.98 Unrealized —

— Ampio Pharmaceuticals Inc. 3.3%

Value $2.191M Shares 2,738,322 Est. Cost $6.03 Unrealized —

VNRX Volition RX LTD 2.8%

Value $1.855M Shares 461,538 Est. Cost $3.75 Unrealized +17.8%

— Alcobra Ltd 2.1%

Value $1.374M Shares 1,205,498 Est. Cost $6.71 Unrealized —

— Summit Therapeutics PLC 2.0%

Value $1.327M Shares 100,000 Est. Cost $13.27 Unrealized —

— Keryx Biopharmaceuticals Inc. 1.9%

Value $1.232M Shares 200,000 Est. Cost $10.21 Unrealized —

— Ritter Pharmaceuticals, Inc 1.7%

Value $1.139M Shares 802,434 Est. Cost $2.12 Unrealized —

— Neurotrope Inc 1.3%

Value $867K Shares 45,388 Est. Cost $19.10 Unrealized —

ALDX Aldeyra Therapeutics Inc 0.9%

Value $620K Shares 124,096 Est. Cost $10.20 Unrealized -49.5%

— Caladrius Biosciences Inc 0.9%

Value $593K Shares 117,957 Est. Cost $3.99 Unrealized —

— Evoke Pharma Inc 0.8%

Value $543K Shares 175,000 Est. Cost $3.10 Unrealized —

— Advaxis Inc. 0.8%

Value $500K Shares 112,500 Est. Cost $3.96 Unrealized —

FOLD Amicus Therapeutics Inc. 0.5%

Value $357K Shares 50,000 Est. Cost $6.32 Unrealized 0.0%

Ticker	Issuer	Shares	Value	%	Est. Cost	Unrealized	Class	CUSIP
—	Corbus Pharmaceuticals HLDGS	3,738,925	$30.85M	46.5%	$4.33	—	COM	21833P103
—	Abeona Therapeutics Inc	2,359,767	$11.74M	17.7%	$4.97	—	COM	00289Y107
—	Vascular Biogenics LTD	860,605	$4.733M	7.1%	$4.61	—	COM	M96883109
AVXL	Anavex Life Sciences Corp	724,205	$4.157M	6.3%	$3.56	+45.0%	COM NEW	032797300
—	Newlink Genetics Corp	93,533	$2.254M	3.4%	$27.98	—	COM	651511107
—	Ampio Pharmaceuticals Inc.	2,738,322	$2.191M	3.3%	$6.03	—	COM	03209T109
VNRX	Volition RX LTD	461,538	$1.855M	2.8%	$3.75	+17.8%	COM	928661107
—	Alcobra Ltd	1,205,498	$1.374M	2.1%	$6.71	—	SHS	M2239P109
—	Summit Therapeutics PLC	100,000	$1.327M	2.0%	$13.27	—	SPONS ADS	86627R102
—	Keryx Biopharmaceuticals Inc.	200,000	$1.232M	1.9%	$10.21	—	COM	492515101
—	Ritter Pharmaceuticals, Inc	802,434	$1.139M	1.7%	$2.12	—	COM	767836109
—	Neurotrope Inc	45,388	$867K	1.3%	$19.10	—	COM NEW	64129T207
ALDX	Aldeyra Therapeutics Inc	124,096	$620K	0.9%	$10.20	-49.5%	COM	01438T106
—	Caladrius Biosciences Inc	117,957	$593K	0.9%	$3.99	—	COM NEW	128058203
—	Evoke Pharma Inc	175,000	$543K	0.8%	$3.10	—	COM	30049G104
—	Advaxis Inc.	112,500	$500K	0.8%	$3.96	—	W EXP 07/15/201	007624117
FOLD	Amicus Therapeutics Inc.	50,000	$357K	0.5%	$6.32	0.0%	COM	03152W109